Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
Advanced Enzyme Technologies IPO is a book build issue of ₹411.49 crores. The issue is a combination of fresh issue of 0.06 crore shares aggregating to ₹50.19 crores and offer for sale of 0.40 crore shares aggregating to ₹361.30 crores.
Advanced Enzyme Technologies IPO bidding started from Jul 20, 2016 and ended on Jul 22, 2016. The shares got listed on BSE, NSE on Aug 1, 2016.
Advanced Enzyme Technologies IPO price band is set at ₹896.00 per share . The lot size for an application is 16. The minimum amount of investment required by an retail is ₹14,080 (16 shares). The lot size investment for sNII is 14 lots (224 shares), amounting to ₹2,00,704, and for bNII, it is 70 lots (1,120 shares), amounting to ₹10,03,520.
The issue includes a reservation of up to 24,691 shares for employees offered at a discount of ₹86.00 to the issue price.
Axis Capital Ltd. is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue.
Refer to Advanced Enzyme Technologies IPO RHP for detailed Information.
| IPO Date | July 20, 2016 to July 22, 2016 |
| Listing Date | August 1, 2016 |
| Face Value | ₹10 per share |
| Issue Price Band | ₹880 to ₹896 per share |
| Issue Price Final | ₹896 per share |
| Lot Size | 16 Shares |
| Sale Type | Fresh Capital-cum-Offer for Sale |
| Total Issue Size | 45,94,875 shares (aggregating up to ₹411.49 Cr) |
| Fresh Issue | 5,60,405 shares (aggregating up to ₹50.19 Cr) |
| Offer for Sale | 40,34,470 shares of ₹10 (aggregating up to ₹361.30 Cr) |
| Employee Discount | ₹86.00 |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Share Holding Pre Issue | 2,17,65,600 shares |
| Share Holding Post Issue | 2,23,26,005 shares |
Advanced Enzyme IPO offers total 45,94,875 shares. Out of which 22,85,091 (49.73%) allocated to QIB, 9,14,038 (19.89%) allocated to QIB, 6,85,528 (14.92%) allocated to NII, 15,99,565 (34.81%) allocated to RII and 13,71,053 (29.84%) allocated to Anchor investors.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| QIB Shares Offered | 22,85,091 (49.73%) | NA |
| − Anchor Investor Shares Offered | 13,71,053 (29.84%) | NA |
| − QIB (Ex. Anchor) Shares Offered | 9,14,038 (19.89%) | NA |
| NII (HNI) Shares Offered | 6,85,528 (14.92%) | NA |
| Retail Shares Offered | 15,99,565 (34.81%) | 99,972 |
| Employee Shares Offered | 24,691 (0.54%) | NA |
| Total Shares Offered | 45,94,875 (100.00%) |
| Application Category | Maximum Bidding Limits | Bidding at Cut-off Price Allowed |
|---|---|---|
| Only RII | Up to Rs 2 Lakhs | Yes |
| Only sNII | Rs 2 Lakhs to Rs 10 Lakhs | No |
| Only bNII | Rs 10 Lakhs to NII Reservation Portion | No |
| Only employee | Yes | |
| Employee + RII/NII |
|
Yes for Employee and RII/NII |
Advanced Enzyme Technologies IPO opens on July 20, 2016, and closes on July 22, 2016.
| IPO Open Date | Wed, Jul 20, 2016 |
| IPO Close Date | Fri, Jul 22, 2016 |
| Tentative Listing Date | Mon, Aug 1, 2016 |
| Cut-off time for UPI mandate confirmation | 5 PM on Fri, Jul 22, 2016 |
Investors can bid for a minimum of 16 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 16 | ₹14,336 |
| Retail (Max) | 13 | 208 | ₹1,86,368 |
| S-HNI (Min) | 14 | 224 | ₹2,00,704 |
| S-HNI (Max) | 69 | 1,104 | ₹9,89,184 |
| B-HNI (Min) | 70 | 1,120 | ₹10,03,520 |
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
Incorporated in 1989, Advanced Enzyme Technologies Ltd is an India based company engaged in research, development, manufacturing and marketing of Healthcare, Nutrition and Bio-Processing products. Information in this paragraph is copied from chittorgarh.com.
Company produces over 400 proprietary products developed from 60 enzymes. Advanced Enzyme operate in two primary business verticals namely Healthcare & Nutrition (human and animal) and Bio-Processing (food and non-food).
Company has 13 patents registered in its name and applications for registration of 4 patents are pending.
Advanced Enzyme is among top 15 companies in enzyme sales in the world and 2nd largest in India. Company has over 20 years of fermentation experience in the production of enzymes. Company offer these products to its more than 700 global customers across 50 countries around the world. Content in this paragraph is copied from chittorgarh.com.
Advanced Enzyme's R&D team consists of over 55 scientists, microbiologists, engineers, food technologists and biotechnologists. Company have four R&D facilities, of which two are located at Thane, and one each at Sinnar and Chino, California.
Competitive strengths of the company:
1. Integrated Company with presence across the Enzyme Value Chain
2. Strong R&D, enzyme development and manufacturing capabilities
3. Specialized Business Model with high entry barriers
4. Diversified Product Portfolio and Wide Customer Base, served by a Strong Sales, Marketing and Distribution network
5. Experienced Promoters and Strong Management Team
6. Financial stability and stable cash flows
| Particulars | For the year/period ended (in Rs. Million) | ||||
|---|---|---|---|---|---|
| 31-Mar-16 | 31-Mar-15 | 31-Mar-14 | 31-Mar-13 | 31-Mar-12 | |
| Total Assets | 4,516.50 | 4,180.92 | 4,082.76 | 3,963.47 | 3,490.09 |
| Total Revenue | 2,946.37 | 2,242.69 | 2,404.81 | 2,241.15 | 1,748.78 |
| Profit After Tax (PAT) | 784.35 | 501.02 | 200.86 | 492.19 | 333.36 |
The Offer consists of a Fresh Issue by the company and an Offer for Sale by the Selling Shareholders.
1. Offer for Sale
Company will not receive any proceeds from the Offer for Sale.
2. The Fresh Issue
The object of the fresh issue is to invest in Advanced Enzymes USA, the wholly owned subsidiary for repayment / pre-payment of certain loans availed by Advanced Enzymes USA; and general corporate purposes.
[Dilip Davda] Being first mover IPO in the enzymes segment, it is catching fancy. Considering its track records and future prospects ahead, investors may consider investment for short to long term rewards. Read detail review...
| Listing Date | August 1, 2016 |
| BSE Script Code | 540025 |
| NSE Symbol | ADVENZYMES |
| ISIN | INE837H01012 |
| Final Issue Price | ₹896 per share |
| BSE Listing Group | B |
Advanced Enzyme Technologies Ltd.
Sun Magnetica, 5th Floor,
Near LIC Service Road, Louiswadi,
Thane 400604, Maharashtra, India
Thane, Maharashtra
Phone: +91-22-4170 3200
Email: prabal@adavancedenzymes.com
Website: http://www.advancedenzymes.com
MUFG Intime India Pvt.Ltd.
Phone: +91-22-4918 6270
Email: aetl.ipo@linkintime.co.in
Website: https://linkintime.co.in/Initial_Offer/public-issues.html
Advanced Enzyme Technologies IPO is a main-board IPO of 45,94,875 equity shares of the face value of ₹10 aggregating up to ₹411.49 Crores. The issue is priced at ₹896 per share. The minimum order quantity is 16.
The IPO opens on July 20, 2016, and closes on July 22, 2016.
MUFG Intime India Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Advanced Enzyme Technologies IPO using UPI as a payment gateway. Zerodha customers can apply in Advanced Enzyme Technologies IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Advanced Enzyme Technologies IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Advanced Enzyme Technologies IPO opens on July 20, 2016 and closes on July 22, 2016.
Advanced Enzyme Technologies IPO lot size is 16, and the minimum amount required for application is ₹14,336.
You can apply in Advanced Enzyme Technologies IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Advanced Enzyme Technologies IPO will be done on [.], and the allotted shares will be credited to your demat account by [.]. Check the Advanced Enzyme Technologies IPO allotment status.
The Advanced Enzyme Technologies IPO listing date is on Monday, August 1, 2016.
Useful Articles
RHP